Home/Filings/4/0001127602-25-001620
4//SEC Filing

Francois Cedric 4

Accession 0001127602-25-001620

CIK 0001492422other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:04 PM ET

Size

10.8 KB

Accession

0001127602-25-001620

Insider Transaction Report

Form 4
Period: 2025-01-17
Francois Cedric
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2025-01-21+130,662432,070 total
  • Sale

    Common Stock

    2025-01-17$29.96/sh6,007$179,959301,408 total
Holdings
  • Common Stock

    (indirect: By Trust)
    234,411
  • Common Stock

    (indirect: By Trust)
    300,000
  • Common Stock

    (indirect: By Trust)
    472,065
  • Common Stock

    (indirect: By Trust)
    532,946
Footnotes (6)
  • [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
  • [F2]This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.
  • [F3]The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
  • [F4]The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
  • [F5]The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
  • [F6]The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001658080

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:04 PM ET
Size
10.8 KB